NAB2 and neoplasm: SFT is characterized by the NAB2-STAT6 fusion, which exhibits variable breakpoints and drives STAT6 nuclear expression.[12] Given that NAB2-STAT6 fusion was not identified in our patient's tumor, the SFT was excluded.